Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
Vaginitis, Vulvar Diseases
About this trial
This is an interventional screening trial for Vaginitis
Eligibility Criteria
Inclusion Criteria: Must be 18 years of age Has histologically confirmed non-malignant vulvar pathology Is scheduled or planning for WLE/SPV Signed informed consent obtained prior to any protocol specific procedures Exclusion Criteria: Unable to give informed consent Women who are pregnant or nursing (lactating) women at time of consent No prior RT No recent antibiotic use within the last 3 weeks or 5.5 times the half-life of the antibiotic (whichever is shorter) No history of prior malignancy within the last 3 years that required systemic chemotherapy or radiation Not immunosuppressed or compromised No active HIV (must have undetectable viral load) Chronic treatment with corticosteroids or other immunosuppressive agents including topical corticosteroids in the pelvis. Inhaled corticosteroids are allowed No active uncontrolled severe infections (not responding to antibiotics), except acute or chronic pelvic inflammatory disease Uncontrolled diabetes mellitus
Sites / Locations
- University of Virginia